Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Mar
2
2022
Initiating Action With Only Brain Power Womble Bond Dickinson (US) LLP
Mar
2
2022
Similac Baby Formula Recall & Enfamil and Similac Formula Lawsuits Buckfire Law
Mar
2
2022
Lawsuit Filed Over Misleadingly Labeled “Brown Bread” Keller and Heckman LLP
Mar
1
2022
FDA Issues Proposed Rule to Amend Medical Device Quality System Regulation McDermott Will & Emery
Mar
1
2022
Unpacking Averages: Connecting Published Clinical Trials with FDA Drug Approvals Epstein Becker & Green, P.C.
Mar
1
2022
Massachusetts COVID-19 Emergency Paid Sick Leave Act to End on March 15, 2022 Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Mar
1
2022
Keurig Agrees to Pay $10 Million to Settle Class Action Over Charges of Misleading Recyclable Claims Keller and Heckman LLP
Mar
1
2022
FDA Releases New PFAS Test Results Keller and Heckman LLP
Mar
1
2022
Two Food Standards Agency (FSA) Food Law Consultations Opened – Novel Foods and Precautionary Allergen Labelling Squire Patton Boggs (US) LLP
Mar
1
2022
U.S. Department of Transportation Publishes Proposed Rules For Oral Fluid Drug Testing Jackson Lewis P.C.
Mar
1
2022
Treasury Department Recommends Antitrust Reform in Alcohol Markets Sheppard, Mullin, Richter & Hampton LLP
Feb
28
2022
China on the Move: Lesson from China’s National Negotiation of Drug Prices in 2021 Greenberg Traurig, LLP
Feb
28
2022
EUON Publishes Nanopinion on How to Assess the Risks of Nanoplastics Bergeson & Campbell, P.C.
Feb
28
2022
What is Driving Increasing Investment in AgTech Sector Foley & Lardner LLP
Feb
28
2022
Arguments Over Label of Kirkland ‘Black Raspberry’ Sparkling Water Keller and Heckman LLP
Feb
28
2022
Prop 65 Lists PFOA As Carcinogen CMBG3 Law
Feb
25
2022
U.S. Supreme Court Hears Rare 340B Drug Pricing Program Matter with Significant Reimbursement Implications Polsinelli PC
Feb
25
2022
The Fun and Whimsical (but Crowded) Landscape of Beer Names: Part 1 Ward and Smith, P.A.
Feb
25
2022
The Fun and Whimsical (but Crowded) Landscape of Beer Names Part 1 Ward and Smith, P.A.
Feb
24
2022
GT Legal Food Talk Episode 14: Bioengineering in 2022: What’s in My Food? [PODCAST] Greenberg Traurig, LLP
Feb
24
2022
FSIS Proposes Pork Standards to Address Salmonella Keller and Heckman LLP
Feb
24
2022
Long-Felt Need Not Felt Long Enough to Overcome Obviousness McDermott Will & Emery
Feb
24
2022
Federal Circuit Divided on Whether Skinny Labeling Compliance Precludes Inducement or Supports Equitable Estoppel McDermott Will & Emery
Feb
24
2022
NanoHarmony Survey Identifies Challenges in OECD Test Guidelines Development, Will Hold Webinar on March 1 Bergeson & Campbell, P.C.
Feb
23
2022
NY AG Demands Removal of False “Lead Free” Baby Food Claims Keller and Heckman LLP
Feb
22
2022
Episode 20: Who’s The Boss: Convergence and Consolidation in Cancer Care [PODCAST] Foley & Lardner LLP
Feb
22
2022
EPA’s Biofuels Webinar Series Will Include Webinar on TSCA Requirements and the PMN Process on February 23, 2022 Bergeson & Campbell, P.C.
Feb
22
2022
TTB Publishes Phase 2 of Labeling and Advertising Modernization Rule McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins